You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity

    SBC: IMMURX LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): We have discovered, characterized and functionally defined a novel, immune inhibitory ligand. This ligand is hematopoietically-expressed, a distant member of the B7 Ig-superfamily, and its extracellular domain bears homology to the B7 family ligand PD-L1. This molecule is designated as V-domain Immunoglobulin Suppressor of T cell Activation (VISTA). Distinct fr ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Scleroderma Subtyping from Fresh and Archived Biopsies using NextGen Sequencing

    SBC: CELDARA MEDICAL, LLC            Topic: NIAMS

    DESCRIPTION (provided by applicant): Systemic sclerosis (SSc) is an autoimmune disease that presents with a heterogeneous and complex phenotype. Major manifestations of the disease are skin fibrosis, vascular dysfunction, and immune system activation. There are no validated diagnostic markers. There are no curative treatments. One in three patients dies within 10 years of diagnosis. Some drugs (de ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies

    SBC: Woomera Therapeutics, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): The objective of this Phase 1 project is to improve an effective treatment of recurrent small-cell lung cancer (rSCLC) by targeting a tumor-specific abnormal receptor, AbnV2 that is a surface-marker of the disease. Currently, there is no effective treatment for rSCLC. Our data show expression of this abnormal vasopressin V2 receptor (AbnV2 ) is a common featur ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. Foley Urological Catheter Insertion Tool and Method

    SBC: UROVALVE, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Urovalve, Inc. is developing a novel, patent pending insertion device preassembled to a Foley catheter. The Surinate(R) Foley Catheter with Inserter System is designed to enable skilled healthcare professionals such asurologists and experienced urological nurses to insert smaller, softer, more comfortable Foley catheters, especially in those instances in which ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Concentrating anti-UTI phytochemicals from cranberry in a functional food matrix

    SBC: Nutrasorb LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): The overall goal of this Phase 1 SBIR proposal resubmission (revised according the recommendations of the review panel) is to demonstrate that the biologically-active phytochemicals naturally present in the American cranberry, in particular, the anti-infective A-type proanthocyanidins that are clearly linked to prevention of urinary tract infections (UTIs) in h ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Decision Support System for Predicting outcome of ER+ breast cancers

    SBC: IBRIS, INC.            Topic: NIBIB

    DESCRIPTION (provided by applicant): We propose an alternative, inexpensive means for identifying the subset of women with ER+ breast cancer for whom hormonal therapy alone is sufficient, and adjuvant chemotherapy is not required. Our novel approach uses computer vision and machine learning techniques to extract information from digitized histological sections of breast tissue (e.g. graphical and ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Tagging of Histopathology Specimens with Light-Activated RFID Chips

    SBC: Pharmaseq, Inc            Topic: NIGMS

    DESCRIPTION (provided by applicant): The purpose of the present project is to demonstrate the feasibility of using a novel RFID chip to tag and track tissue cassettes and glass slides that are used in histopathology laboratories. The system is based on thePharmaSeq laser light-activated microtransponder, also known as p-Chip . The chip's major advantages are its small size (500 5m x 500 5m x ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. An Innovative New Stroke Rehabilitation Tool: The Shoulder SOS

    SBC: MEDEON, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Where arm functioning has been compromised due to a stroke, brain injury, or other neurological injury and rehabilitative progress is to be obtained in the upper extremity, it is crucial to limit over-stretching of theshoulder joint (attributed to lost muscle tone) and to control pain. Medeon, LLC is actively working with rehabilitation experts to develop the ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. A Biomimetic Prehensile Digit for Upper-Limb Prostheses

    SBC: Invisible Hand Enterprises, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Among amputation types involving the upper limbs, partial hand is the most prevalent by far and among the most challenging for prosthetists to address well. Sound side overreliance for these amputees gives rise to a high prevalence of contralateral overuse syndrome (COS), a progressive, painful, and debilitating condition. Research shows that prostheses reduce ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Development of algorithm for identification of functional self-delivering RNAi co

    SBC: ADVANCED RNA TECHNOLOGIES, LLC            Topic: NHGRI

    DESCRIPTION (provided by applicant): Introduction of small interfering RNAs (siRNAs) into cells with transfection reagents results in efficient gene silencing. Unfortunately, while siRNA-based functional genomics is widely used in vitro, the ability to apply this technology to primary cells and in vivo target validation has been impeded limited availability of efficient and non-toxic delivery syst ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government